Vitenskapelig artikkel

• Guerra, Clara Lucas; Vold, Jørn Henrik; Aas, Christer Frode et al. (2025). Associations between happiness with social factors and opioid agonist therapy among people who inject drugs. (ekstern lenke)
• Arjmand, Elaheh Javadi; Thomassen, Lise Margrete; Druckrey-Fiskaaen, Karl Trygve et al. (2025). The effect of fruit smoothie supplementation on psychological distress and biomarkers among people with opioid dependence receiving opioid agonist therapy: a randomized controlled trial. (ekstern lenke)
• Vold, Jørn Henrik; Vogt, Elinor Margrethe Chelsom; Heldal, Anne Taraldsen et al. (2025). Low Testosterone Among Males in Opioid Agonist Therapy and Its Association With Fatigue and Psychological Distress. (ekstern lenke)
• Furulund, Einar; Carlsen, Siv-Elin Leirvåg; Alpers, Silvia Eiken et al. (2025). Integrating an exercise program into opioid agonist therapy: a pilot study on feasibility, fitness improvements, and participation challenges. (ekstern lenke)
• Carlsen, Siv-Elin Leirvåg; Furulund, Einar; Arjmand, Elaheh Javadi et al. (2025). To smoothie or not to smoothie? A mixed-method approach of nutrition pilot intervention among individuals in opioid agonist treatment. (ekstern lenke)
• Druckrey-Fiskaaen, Karl Trygve; Madebo, Tesfaye; Carlsen, Siv-Elin Leirvåg et al. (2025). Multimethod feasibility evaluation of smoking cessation intervention for patients receiving opioid agonist therapy. (ekstern lenke)
• Druckrey-Fiskaaen, Karl Trygve; Madebo, Tesfaye; Daltveit, Jan Tore et al. (2025). Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy: A Randomized Clinical Trial. (ekstern lenke)
• Furulund, Einar; Madebo, Tesfaye; Druckrey-Fiskaaen, Karl Trygve et al. (2024). Integrated exercise program in opioid agonist therapy clinics and effect on psychological distress: study protocol for a randomized controlled trial (BAReAktiv). (ekstern lenke)
• Alpers, Silvia Eiken; Druckrey-Fiskaaen, Karl Trygve; Madebo, Tesfaye et al. (2024). The association of psychological distress and economic and health worries with tobacco smoking behavior during the COVID-19 pandemic: a two-year longitudinal cohort study. (ekstern lenke)
• Aas, Christer Frode; Vold, Jørn Henrik; Chalabianloo, Fatemeh et al. (2024). Effect of integrated hepatitis C virus treatment on psychological distress in people with substance use disorders. (ekstern lenke)
• Druckrey-Fiskaaen, Karl Trygve; Vold, Jørn Henrik; Madebo, Tesfaye et al. (2024). Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study. (ekstern lenke)
• Druckrey-Fiskaaen, Karl Trygve; Madebo, Tesfaye; Daltveit, Jan Tore et al. (2024). Update of statistical analysis plan for: Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). (ekstern lenke)
• Gryte, Odin Handeland; Meland, Eivind; Samdal, Gro Beate et al. (2024). Physical activity and sedentary time after lifestyle interventions at the Norwegian Healthy Life Centres. (ekstern lenke)
• Alpers, Silvia Eiken; Pallesen, Ståle; Vold, Jørn Henrik et al. (2023). The association between psychological distress and alcohol consumption and physical activity: a population-based cohort study. (ekstern lenke)
• Vold, Jørn Henrik; Halmøy, Anne; Chalabianloo, Fatemeh et al. (2023). Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study. (ekstern lenke)
• Lim, Aaron Guanliang; Aas, Christer Frode; Caglar, Ege Su et al. (2023). Cost-effectiveness of integrated treatment for hepatitis C virus (HCV) among people who inject drugs in Norway: An economic evaluation of the INTRO-HCV trial. (ekstern lenke)
• Arjmand, Elaheh Javadi; Skogen, Jens Christoffer; Vold, Jørn Henrik et al. (2023). Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study. (ekstern lenke)
• Arjmand, Elaheh Javadi; Mitra, Bemanian; Vold, Jørn Henrik et al. (2023). Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway. (ekstern lenke)
• Vold, Jørn Henrik; Chalabianloo, Fatemeh; Løberg, Else-Marie et al. (2023). The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial. (ekstern lenke)
• Åstrøm, Anne-Kristine N; Vold, Jørn Henrik; Aas, Christer Frode et al. (2022). Association between oral and general health related quality of life among Norwegian patients with substance use disorders in opioid agonist therapy. (ekstern lenke)
• Mydske, Sigurd; Haukeland, Irene Cimafranca; Godø, Ann Helen et al. (2022). En kvinne i 20-årene med paranoide vrangforestillinger. (ekstern lenke)
• Vold, Jørn Henrik; Løberg, Else-Marie; Aas, Christer Frode et al. (2022). Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway. (ekstern lenke)
• Mitra, Bemanian; Vold, Jørn Henrik; Chowdhury, Ranadip et al. (2022). Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway. (ekstern lenke)
• Druckrey-Fiskaaen, Karl Trygve; Furulund, Einar; Daltveit, Jan Tore et al. (2022). Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR). (ekstern lenke)
• Mitra, Bemanian; Chowdhury, Ranadip; Stokke, Krister et al. (2022). Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway. (ekstern lenke)
• Chalabianloo, Fatemeh; Høiseth, Gudrun; Vold, Jørn Henrik et al. (2022). Impact of liver fibrosis and clinical characteristics on dose-adjusted serum methadone concentrations. (ekstern lenke)
• Madebo, Tesfaye; Mitra, Bemanian; Vold, Jørn Henrik et al. (2022). Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway. (ekstern lenke)
• Vold, Jørn Henrik; Gjestad, Rolf; Aas, Christer F. et al. (2021). Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020. (ekstern lenke)
• Aas, Christer Frode; Vold, Jørn Henrik; Gjestad, Rolf et al. (2021). Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway. (ekstern lenke)
• Chalabianloo, Fatemeh; Fadnes, Lars T.; Høiseth, Gudrun et al. (2021). Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway. (ekstern lenke)
• Fadnes, Lars T.; Aas, Christer Frode; Vold, Jørn Henrik et al. (2021). Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). (ekstern lenke)
• Vold, Jørn Henrik; Chalabianloo, Fatemeh; Aas, Christer Frode et al. (2021). Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020. (ekstern lenke)
• Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana et al. (2020). Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017. (ekstern lenke)
• Vold, Jørn Henrik; Skurtveit, Svetlana; Aas, Christer Frode et al. (2020). Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; A prospective cohort study in Norway from 2013 to 2017. (ekstern lenke)
• Vold, Jørn Henrik; Skurtveit, Svetlana; Aas, Christer et al. (2020). Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study. (ekstern lenke)
• Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana et al. (2020). Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway. (ekstern lenke)
• Vold, Jørn Henrik; Aas, Christer Frode; Skurtveit, Svetlana et al. (2020). Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. (ekstern lenke)
• Vold, Jørn Henrik; Gjestad, Rolf; Aas, Christer Frode et al. (2020). Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020. (ekstern lenke)
• Vold, Jørn Henrik; Aas, Christer Frode; Skurtveit, Svetlana et al. (2020). Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; A national prospective cohort study in Norway from 2015 to 2017. (ekstern lenke)
• Aas, Christer Frode; Vold, Jørn Henrik; Skurtveit, Svetlana et al. (2020). On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017. (ekstern lenke)
• Fadnes, Lars T.; Aas, Christer Frode; Vold, Jørn Henrik et al. (2019). Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Chalabianloo, Fatemeh; Fadnes, Lars T.; Johansson, Kjell Arne et al. (2024). Methadone pharmacokinetics in opioid agonist treatment: Influencing factors and clinical implications. (ekstern lenke)
• Vold, Jørn Henrik; Aas, Christer Frode; Leiva, Rafael Alexander Mo et al. (2019). Integrated care of severe infectious diseases to people with substance use disorders; a systematic review. (ekstern lenke)

Fagartikkel

• Fadnes, Lars T.; Furulund, Einar; Druckrey-Fiskaaen, Karl Trygve et al. (2022). Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR). (ekstern lenke)

Kronikk

• Waal, Helge; Vold, Jørn Henrik; Skurtveit, Svetlana (2020). Kvetiapinmisbruk-myte eller realitet?. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin